InsidersTradesSigma
Track the 联环药业 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 联环药业 has logged 1 insider filings. Market capitalisation: €4.4bn. The latest transaction was filed on 8 November 2024 (Purchase). Among the most active insiders: 王春元. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
联环药业是一家在上海证券交易所上市的健康和制药公司。它专注于药品的研发和生产。